MASI Stock Analysis: Buy, Sell, or Hold?
MASI - Masimo Corporation
$178.59
0.58 (0.33%)
▲
5d:
+0.96%
30d:
+1.84%
90d:
+37.31%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 12, 2026
Get Alerted When MASI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MASI trades at premium valuation expecting 5.4% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: MASI trades at premium valuation expecting 5.4% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$195.79
Based on 5.8% avg growth
INTRINSIC VALUE TODAY
$121.57
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MASI is currently trading at $178.59, which is considered extended relative to its 30-day fair value range of $175.11 to $177.71. From a valuation perspective, the stock is trading at a premium (Forward PE: 30.2) compared to its historical average (25.8). At these levels, the market is pricing in 5.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MASI is in a strong uptrend. The price is currently testing key support at $176.68. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MASI is in a strong uptrend. The price is currently testing key support at $176.68. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$175.11 -
$177.71
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
46.2%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($178.60)
- NEUTRAL: PE elevated vs history but 5.4% growth expectation is conservative given 214% recent growth
Fair Price Analysis
30-Day Fair Range
$175.11 -
$177.71
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$176.68
Resistance Level
$179.00
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
30.22
Wall Street Target
$178.60
Revenue Growth (YoY)
8.2%
Earnings Growth (YoY)
214.4%
Profit Margin
-26.1%
Valuation Premium vs History
+5.4% premium
PE vs Historical
30.2 vs 25.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.4%
(market-implied from PE analysis)
1-Year Target
$188.23
(+5%)
2-Year Target
$198.40
(+11%)
3-Year Target
$209.11
(+17%)
3-Yr Target (if PE normalizes)
(PE: 30→26)
PE COMPRESSION
$178.54
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 30.2, Growth: 7.6%)
$222.64
(+25%)
Base:
(SPY PE: 20.6, Growth: 7.6%)
$151.55
(-15%)
Bear:
(PE: 17.5, Growth: 7.6%)
$128.82
(-28%)
Share & Embed Analysis
Last updated: April 02, 2026 6:47 PM ET
Data refreshes hourly during market hours. Next update: 7:47 PM
Data refreshes hourly during market hours. Next update: 7:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MASI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
